GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (A4G4J9)

Analyse AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A4G4J9
Type
protein
Length
386 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x4Ef77Afb5a3D9F41c95Be3227D1CC986CCb61835
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
A4G4J9
Pockets
3 · best druggability 0.81

Structure

1 distinct chain · 39% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein38639% helix, 19% strandA4G4J9

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11560.810.9731empty
23520.700.8337empty
31390.400.7423empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.